bluebird bio Announces Closing of Public Offering of Common Stock ...

The shares were offered by bluebird bio pursuant to an automatically effective shelf registration statement that was previously filed with the Securities and ...

bluebird bio Announces Closing of Initial Public Offering and ...

The company's common stock is listed on The NASDAQ Global Select Market under the trading symbol “BLUE.” J.P. Morgan Securities LLC and BofA Merrill Lynch are ...

bluebird bio Announces Closing of Over-Allotment Option in Public ...

The shares were offered by bluebird bio pursuant to an automatically effective shelf registration statement that was previously filed with the Securities and ...

bluebird bio Announces Pricing of Public Offering of Common Stock

The offering is expected to close on or about May 21, 2020 , subject to customary closing conditions. bluebird bio anticipates the total gross proceeds from ...

Bluebird Bio Announces Closing Of IPO, Exercise Of Over-Allotment ...

bluebird bio, Inc., announced the closing of its initial public offering of 6.8 million shares of common stock at an initial public offering price of $17.00 ...

bluebird bio, Inc. Announces Pricing of $125 Million Public Offering ...

(Nasdaq: BLUE) (“bluebird”) today announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public offering price ...

Bluebird Bio announces proposed public offering of common stock

* Bluebird Bio Inc says it has commenced an underwritten public offering of $350 million of its common stock Source text for Eikon: Further ...

bluebird bio, Inc. Announces Pricing of $125 Million Public Offering ...

(Nasdaq: BLUE) ("bluebird") today announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public ...

bluebird bio, Inc. Announces Proposed Public Offering of Common ...

(Nasdaq: BLUE) has announced a public offering of $150,000,000 of its common stock, with an option for underwriters to purchase an additional ...

bluebird bio, Inc. Announces Pricing of $125 Million Public Offering ...

bluebird bio, Inc. (Nasdaq: BLUE) announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public ...

bluebird bio proposes public offering of $150 million common stock

bluebird bio proposes public offering of $150 million common stock. ... Biotechnology News · bluebird bio proposes public offering of $150 ...

Cash-strapped bluebird proposes public offering of stock

In an effort to raise cash, bluebird bio announced that it has commenced an underwritten public offering of $150 million of shares of its common ...

bluebird bio Announces Pricing of Public Offering of Common Stock

bluebird bio anticipates the total gross proceeds from the offering (before deducting underwriters' discounts and commissions and estimated offering expenses) ...

bluebird Seeks Funding Through 2024 with New Public Offering

bluebird bio, Inc. is expecting gross proceeds of $120 million with its newly announced public offering of 20000000 shares.

bluebird bio Announces First Quarter 2023 Earnings Date and ...

All shares of common stock and pre-funded warrants are being offered by TELA. The offering is expected to close on or about October 24, 2024, ...

bluebird bio, Inc. announces pricing of $120M public offering of ...

bluebird bio, Inc. today announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock at a public ...

bluebird bio Announces Pricing of Public Offering of Common Stock

The shares are being offered by bluebird bio pursuant to an automatically effective shelf registration statement that was previously filed with the Securities ...

Bluebird Bio Prices Public Offering Of 83.33 Mln Shares At $1.50/shr ...

(RTTNews) - bluebird bio Inc. (BLUE) said that it has priced its underwritten public offering of about 83.33 million shares of its common ...

Calidi Biotherapeutics Announces Closing of $7.5 Million Public ...

(NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today ...

Bluebird Bio's stock falls after proposed public stock offering

Shares of Bluebird Bio Inc. fell 2.9% in premarket trading Monday, after the gene therapy company said it was proposing a public offering of ...